These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8911654)

  • 1. Neurohormonal perturbations in fibromyalgia.
    Crofford LJ; Engleberg NC; Demitrack MA
    Baillieres Clin Rheumatol; 1996 May; 10(2):365-78. PubMed ID: 8911654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia.
    Crofford LJ; Pillemer SR; Kalogeras KT; Cash JM; Michelson D; Kling MA; Sternberg EM; Gold PW; Chrousos GP; Wilder RL
    Arthritis Rheum; 1994 Nov; 37(11):1583-92. PubMed ID: 7980669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine immunology of fibromyalgia.
    Di Franco M; Iannuccelli C; Valesini G
    Ann N Y Acad Sci; 2010 Apr; 1193():84-90. PubMed ID: 20398012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
    J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome.
    Crofford LJ; Demitrack MA
    Rheum Dis Clin North Am; 1996 May; 22(2):267-84. PubMed ID: 8860799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine abnormalities in fibromyalgia and related disorders.
    Crofford LJ
    Am J Med Sci; 1998 Jun; 315(6):359-66. PubMed ID: 9638892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome.
    Crofford LJ
    Z Rheumatol; 1998; 57 Suppl 2():67-71. PubMed ID: 10025087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients.
    Neeck G
    Scand J Rheumatol Suppl; 2000; 113():8-12. PubMed ID: 11028824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein.
    Riedel W; Schlapp U; Leck S; Netter P; Neeck G
    Ann N Y Acad Sci; 2002 Jun; 966():483-90. PubMed ID: 12114308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal pertubations in fibromyalgia syndrome.
    Neeck G; Riedel W
    Ann N Y Acad Sci; 1999 Jun; 876():325-38; discussion 339. PubMed ID: 10415628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D; Press J
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome.
    Neeck G; Crofford LJ
    Rheum Dis Clin North Am; 2000 Nov; 26(4):989-1002. PubMed ID: 11084955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine abnormalities in fibromyalgia.
    Adler GK; Manfredsdottir VF; Creskoff KW
    Curr Pain Headache Rep; 2002 Aug; 6(4):289-98. PubMed ID: 12095464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine therapy of fibromyalgia syndrome: an update.
    Sarzi-Puttini P; Atzeni F; Cazzola M
    Ann N Y Acad Sci; 2010 Apr; 1193():91-7. PubMed ID: 20398013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.
    Demitrack MA; Crofford LJ
    Ann N Y Acad Sci; 1998 May; 840():684-97. PubMed ID: 9629295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated adrenergic responses to exercise in women with fibromyalgia--a controlled study.
    Giske L; Vøllestad NK; Mengshoel AM; Jensen J; Knardahl S; Røe C
    Eur J Pain; 2008 Apr; 12(3):351-60. PubMed ID: 17827042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.